Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03515005 · ClinicalTrials.gov registry record · NA

Using Lay Health Advisors to Improve Hypertension Management

A NA study, sponsored by MetroHealth Medical Center.

Terminated
Registry status
NA
Development phase
69
Enrollment target

NCT03515005: Clinical Trial NA study, sponsored by MetroHealth Medical Center.

NCT03515005 is a NA study that was terminated before completion, run by MetroHealth Medical Center. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03515005, a NA study, was terminated before completion, sponsored by MetroHealth Medical Center.

TERMINATED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

Hypertension disproportionately affects and is inadequately controlled among African American and poor populations. The investigators propose to determine the impact of using trained lay health advisors to help patients address social contextual factors that influence the management of hypertension.

Primary Outcome

Difference between final and initial systolic and diastolic blood pressure readings

Interventions

  • BEHAVIORAL Lay Health Advisor

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2018-12-03
Est. Completion 2019-09-01
Phase NA
MetroHealth Medical Center

76 total trials

Why NCT03515005 stopped before completion

NCT03515005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Lay Health Advisor is the first listed.

NCT03515005 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03515005 about?

NCT03515005 is a clinical study titled "Using Lay Health Advisors to Improve Hypertension Management". Hypertension disproportionately affects and is inadequately controlled among African American and poor populations. The investigators propose to determine the impact of using trained lay health advisors to help patients address social contextual factors that influence the management of hypertension.

What is the current status of trial NCT03515005?

This trial is currently terminated. It is a NA study. The enrollment target is 69 participants. The study started on 2018-12-03. Estimated completion is 2019-09-01.

What interventions are being tested in trial NCT03515005?

The interventions under investigation include: Lay Health Advisor (BEHAVIORAL).

Who is sponsoring clinical trial NCT03515005?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03515005's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03515005, the US trial registry maintained by the National Library of Medicine. NCT03515005 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.